If this is your first molecular dynamics simulation and you are reviewing trajectory files, energy plots, and RMSD graphs, this note is for you. MD output can seem daunting at first. Common summary measures such as RMSD, RMSF, and energy plots are difficult to interpret without knowing what to look for.
This note explains the main diagnostics for drug discovery: their physical meaning, normal ranges, warning patterns, and issues to raise with your computational contact. It assumes a protein-ligand complex in explicit solvent, simulated at 300 K with AMBER, CHARMM, or OPLS, for 50 and 500 nanoseconds.
RMSD: does the protein remain stable?
RMSD means root mean square deviation. In an MD trajectory, it measures the current protein structure's difference from the starting structure, usually the minimized crystal structure used for setup. The calculation generally uses backbone atoms or all heavy atoms.
A well-behaved globular protein often shows an RMSD rise during the first few nanoseconds, followed by a fairly flat plateau. The rise reflects equilibration as the protein moves from idealized crystal packing into a solvated environment. The plateau is the desired pattern: the protein has settled into a stable conformation and fluctuates around it instead of continuously drifting to another structural state.
For a rigid domain such as a kinase ATP-binding domain, a backbone RMSD plateau of 1.5 to 3.0 angstroms from the starting structure is typical of a well-behaved simulation. Values below 1.5 angstroms indicate very little movement, as in highly restrained simulations or very stable domains. Values consistently above 4.0 to 5.0 angstroms indicate a substantial conformational change, which could reflect domain flexibility or a simulation artifact, depending on the moving region.
An RMSD plot that continues upward without a plateau, or has large sudden jumps, often indicates incomplete equilibration or a setup problem, such as an incorrect protonation state, missing disulfide bond, or unresolved clash.
RMSF: which residues move?
RMSF means root mean square fluctuation. RMSD provides one value per time point for movement of the whole structure. RMSF provides one value per residue, showing how much each residue moves around its average position during the simulation.
High RMSF marks flexible regions. In a standard globular protein, high values are expected in loops, termini, and solvent-exposed sections outside secondary-structure contacts. Low RMSF in core alpha helices and beta strands is expected and reassuring.
In drug discovery, the key RMSF question usually concerns binding-site residues. If residues lining the orthosteric pocket have low RMSF, below 1.0 to 1.5 angstroms, the cavity remains stable throughout the simulation, consistent with productive ligand binding. Unusually high values suggest a pocket more flexible than the crystal structure indicates, so docking from one rigid structure may miss how ligands interact with it.
Ligand stability: the most useful output
For protein-ligand MD, the central questions are whether the ligand stays in the binding pocket and preserves its key interactions throughout the simulation.
The clearest test is ligand RMSD against its initial docked pose. A well-bound ligand in a stable complex commonly reaches a plateau of 1.0 to 2.5 angstroms. If ligand RMSD rises above 4 to 5 angstroms and continues climbing, the ligand is likely leaving its initial pose, either by exploring another pocket position or beginning to exit. Expert interpretation is needed to distinguish a genuine finding, where the initial docking pose was not the true bound pose, from a force field parameterization artifact.
MD reports commonly pair the RMSD plot with contact analysis, identifying protein residues within 4 to 4.5 angstroms of the ligand during the trajectory. Consistent contacts, including key hydrogen bond donors and acceptors remaining within bonding distance, indicate a stable binding mode. A major contact shift after equilibration may mean multiple binding poses are being sampled or the initial docking model was wrong.
Energy plots: what matters and what does not
An MD output package may plot total, potential, and kinetic energy, along with temperature, pressure, and volume. Most research use does not require close review of every plot. Check temperature and pressure to verify the intended conditions and identify artifacts. Check total energy to confirm a stable equilibration plateau rather than continued drift.
Some reports include ligand-protein interaction energy, including van der Waals and electrostatic components. This can offer a rough indication of an energetically favorable binding mode, but it is not binding free energy and cannot compare compounds without further analysis. A common first-time error is using interaction energy to rank affinity. It omits solvation, entropy, and sampling-completeness terms, so a plausible-looking value is not necessarily a meaningful affinity estimate.
When to trust the results and when to be cautious
MD is most actionable in drug discovery when it supports or challenges a specific compound's docking pose. A high-scoring docked compound with a rapid RMSD increase, meaning the ligand does not stay put, may deserve lower priority despite its good docking score. A moderate-scoring compound that preserves stable MD contacts may merit closer review than its docking rank suggests.
Use greater caution when the run is very short, less than 50 ns for a typical kinase-sized domain with a drug-like ligand, when ligand force field parameters were generated automatically without validation against known properties, or when the starting structure is a homology model with uncertain binding-site geometry. These conditions do not make the simulation useless, but they limit the weight its output should have in a synthesis decision. Input and setup quality matter at least as much as trajectory length.
